Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-05-01BRNS3Power of Attorney for Douglas Swirsky
This filing details a Power of Attorney granted by Douglas Swirsky, Principal Accounting Officer of Barinthus Biotherapeutics plc, to William Enright, Robert E. Puopolo, and Marishka DeToy. This grants them the authority to execute and file, on behalf of Mr. Swirsky, various SEC forms including Forms 3, 4, and 5, Sched...
Nano CapBiotechnology
2026-04-30BBOT3Form 3 Filing for BridgeBio Oncology Therapeutics, Inc.MEDIUM
This filing details the beneficial ownership of securities for Idan Elmelech, COO & Principal Financial Officer of BridgeBio Oncology Therapeutics, Inc. (BBOT). The filing includes information on directly held Common Stock, specifically 14,838 shares represented by restricted stock units that vest in installments throu...
Small CapBiotechnology
2026-04-30BBOT3Power of Attorney for Marc CoboMEDIUM
This filing details a Power of Attorney granted by Marc Cobo, Principal Accounting Officer of BridgeBio Oncology Therapeutics, Inc., to Pedro Beltran, Idan Elmelech, and Aaron Chan. The attorneys-in-fact are authorized to execute and file SEC forms, including Form 3, 4, and 5, and Schedules 13D and 13G, on behalf of Mr...
Small CapBiotechnology
2026-04-30CDT3Limited Power of Attorney for SEC Reporting PurposesMEDIUM
This filing details a Limited Power of Attorney granted by Ulrik K. Olsen, a director of CDT Equity Inc., to James Bligh and others. This power of attorney authorizes the appointed individuals to act on Mr. Olsen's behalf for all SEC reporting requirements, including obtaining EDGAR credentials, managing the EDGAR acco...
Nano CapBiotechnology
2026-04-30BridgeBio Oncology Therapeutics, Inc.3Power of Attorney for Marc CoboDuplicateMEDIUM
This filing details a Power of Attorney granted by Marc Cobo, Principal Accounting Officer of BridgeBio Oncology Therapeutics, Inc., to Pedro Beltran, Idan Elmelech, and Aaron Chan. The attorneys-in-fact are authorized to execute and file SEC forms, including Form 3, 4, and 5, and Schedules 13D and 13G, on behalf of Mr...
Small CapBiotechnology